首页 › 基金 › Cormorant Asset Management, LP › ORKA
Cormorant Asset Management, LP 对 ORKA 的持仓历史
ORUKA THERAPEUTICS INC · 医疗保健
Cormorant Asset Management, LP 在 Q3 2026 的 13F 申报中披露持有 ORKA(ORUKA THERAPEUTICS INC)400,000 股,市值约 US$33.3M,约占其申报组合的 2.38%,在其申报持仓中市值排名第 13 位。 Cormorant Asset Management, LP 最近 5 个申报季度中有 5 个季度披露了 ORKA 持仓,最早可追溯至 Q3 2025。
最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR
Cormorant Asset Management, LP 对 ORKA 的持仓演变
Cormorant Asset Management, LP 于 Q3 2025 首次披露 ORKA 持仓:533,340 股(约 US$10.3M)。 该持仓在 Q2 2026 达到峰值 533,340 股,市值约 US$50.8M。 在 5 次申报中,Cormorant Asset Management, LP 0 次增持、1 次减持、3 次保持不变。 最近一期申报(Q3 2026)显示持股 400,000 股、市值约 US$33.3M,环比减持 -133,340 股。。 持仓曾出现大幅变动:Q3 2026 减持约 25% (随后一个季度股价上涨 19%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2025 | 533.34K | $10.26M | 新进 |
| Q4 2025 | 533.34K | $16.17M | 持有 |
| Q1 2026 | 533.34K | $26.16M | 持有 |
| Q2 2026 | 533.34K | $50.76M | 持有 |
| Q3 2026 | 400.00K | $33.32M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 ORKA 与 13F 数据
ORKA(ORUKA THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 73 只申报持有 ORKA,申报仓位最大的包括:Venrock Adviser, LLC (US$345.5M), Fairmount Funds Management LLC (US$308.6M), RTW INVESTMENTS, LP (US$261.4M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 ORKA 的基金
- Venrock Adviser, LLC 4.15M 股 · $345.52M · Q3 2026
- Fairmount Funds Management LLC 3.71M 股 · $308.61M · Q3 2026
- RTW INVESTMENTS, LP 3.14M 股 · $261.45M · Q3 2026
- Paradigm Biocapital Advisors LP 2.49M 股 · $207.68M · Q3 2026
- Bellevue Group AG 1.64M 股 · $136.68M · Q3 2026
- RA CAPITAL MANAGEMENT, L.P. 1.55M 股 · $129.48M · Q3 2026
- PERCEPTIVE ADVISORS LLC 1.07M 股 · $89.32M · Q3 2026
- Deep Track Capital, LP 1.07M 股 · $89.10M · Q3 2026
- Remedium Capital Partners, LLC 954.15K 股 · $79.47M · Q3 2026
- Avidity Partners Management LP 785.42K 股 · $65.42M · Q3 2026
- SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 723.92K 股 · $60.30M · Q3 2026
- Affinity Asset Advisors, LLC 600.00K 股 · $49.97M · Q3 2026
更多关于 Cormorant Asset Management, LP
常见问题
How long has Cormorant Asset Management, LP held ORKA?
Cormorant Asset Management, LP has disclosed ORKA holdings in 5 of the last 5 reported quarters, going back to Q3 2025.
What is Cormorant Asset Management, LP's current position in ORKA?
As of Q3 2026, Cormorant Asset Management, LP holds 400.00K shares of ORKA (ORUKA THERAPEUTICS INC), valued at $33.32M, representing 2.38% of its reported portfolio and ranking #13.
Has Cormorant Asset Management, LP been buying or selling ORKA?
In the latest 13F filing (Q3 2026), Cormorant Asset Management, LP reduced its position in ORKA. The position peaked in Q2 2026 at 533.34K shares.
Which other funds hold ORKA?
Other major institutional holders of ORKA include Venrock Adviser, LLC, Fairmount Funds Management LLC, RTW INVESTMENTS, LP, among 73 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.